Alnylam stock drops on rival heart trial: Why analysts see core business safe
Go back to Alnylam stock drops on rival heart trial: Why analysts see core business safe| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 238.27 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $238.27 | 52 Week High | $109.10 | |||
| Open | $238.27 | 52 Week Low | $31.38 | |||
| Day High | $238.27 | P/E | N/A | |||
| Day Low | $238.27 | EPS | $-1.45 | |||
| Volume | 4 | |||||
| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 7,525 | |||||
| (NASDAQ: IONS) | Delayed: 47.25 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $47.25 | 52 Week High | $62.68 | |||
| Open | $47.25 | 52 Week Low | $19.59 | |||
| Day High | $47.25 | P/E | N/A | |||
| Day Low | $47.25 | EPS | $0.00 | |||
| Volume | 1,134 | |||||
